MedTrace Logo

A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients

NCT03581435 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-07-10

No results posted yet for this study

Summary

This research will be the first study for exosome purified from blood in gallbladder carcinoma patients. Proteomics studies will be done in both tumor tissue and the circulating exosome from blood specimens. Then, the potential prognostic and predictive biomarkers will be searched by bioinformatics to find the correlations between exosome biomarkers and gallbladder carcinoma.

Conditions

  • Proteinosis
  • Gallbladder Carcinoma

Sponsors & Collaborators

  • The First Hospital of Jilin University

    collaborator OTHER

  • Shanghai Zhongshan Hosiptal

    collaborator UNKNOWN

  • The First Affiliated Hospital of Bengbu Medical University

    collaborator OTHER

  • Second Affiliated Hospital of Nanchang University

    collaborator OTHER

  • The Affiliated Hospital of Inner Mongolia Medical University

    collaborator OTHER

  • First Affiliated Hospital of Xinjiang Medical University

    collaborator OTHER

  • The First Affiliated Hospital of Shanxi Medical University

    collaborator OTHER

  • Jining Medical University

    collaborator OTHER

  • The Affiliated Hospital of Tianjin Medical University

    collaborator UNKNOWN

  • The first affiliated hospital of Zhongshan university

    collaborator UNKNOWN

  • liu yingbin

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2018-12-30
Completion
2019-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03581435 on ClinicalTrials.gov